Recent Updates
Recently added Catalysts
HAE Positive Sentiment

Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference

Key Takeaway: Haemonetics Corporation will have its President and CEO, Chris Simon, participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026. The event will be available for public viewing through a live webcast, with a replay accessible for 90 days afterward. The company focuses on enhancing healthcare through innovative medical technologies.
Price reaction · baseline $66.37 (2026-06-02 close) · hit pre-market · 1 other HAE headline(s) in the window, move may be shared
day 0 close · peak
-0.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Haemonetics is engaging with investors at a major healthcare conference.
  • The event will be accessible to the public via a live webcast.
  • The company is committed to improving healthcare quality and efficiency.

Full Press Release Details

BOSTON,June 2, 2026/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 4:00 p.m. ET.
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link:https://event.webcasts.com/starthere.jsp?ei=1766065&tp_key=0b16b4b62d&tp_special=8A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.
ABOUT HAEMONETICSHaemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visitwww.haemonetics.com.
Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury David Trenk, Sr. Manager-Investor Relations
(781) 356-9763 (203) 733-4987
olga.guyette@haemonetics.com david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

Frequently Asked Questions

When will Haemonetics present at the conference?

Haemonetics will present on June 8, 2026, at 4:00 p.m. ET.

How can I access the conference presentation?

The presentation can be accessed via a live webcast on Haemonetics' Investor Relations website.

Who will represent Haemonetics at the conference?

Chris Simon, the President and CEO of Haemonetics, will represent the company.

Will there be a replay of the presentation?

Yes, a replay will be available 12 hours after the event for 90 days.

Last updated: Jun 3, 2026